Neogen Financial Statements From 2010 to 2026

NEOG Stock  USD 10.63  0.00  0.00%   
Neogen's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Neogen's valuation are provided below:
Gross Profit
404.8 M
Profit Margin
(0.68)
Market Capitalization
2.3 B
Enterprise Value Revenue
3.4068
Revenue
880.3 M
There are over one hundred nineteen available fundamental ratios for Neogen, which can be analyzed over time and compared to other ratios. Active traders should verify all of Neogen last-minute fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. The Neogen's current Enterprise Value is estimated to increase to about 1.9 B, while Market Cap is projected to decrease to roughly 580 M.

Neogen Total Revenue

1.08 Billion

Check Neogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 151.7 M, Interest Expense of 86.5 M or Total Revenue of 1.1 B, as well as many indicators such as Price To Sales Ratio of 1.21, Dividend Yield of 0.0 or PTB Ratio of 0.52. Neogen financial statements analysis is a perfect complement when working with Neogen Valuation or Volatility modules.
  
Build AI portfolio with Neogen Stock
Check out the analysis of Neogen Correlation against competitors.
For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.

Neogen Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.2 BB1.6 B
Slightly volatile
Short and Long Term Debt Total1.1 BB287.2 M
Slightly volatile
Other Current Liabilities67.5 M64.3 M27.8 M
Slightly volatile
Total Current Liabilities210.1 M200.1 M76.2 M
Slightly volatile
Property Plant And Equipment Net537.9 M409.7 M147.1 M
Slightly volatile
Cash155.8 M148.4 M86.2 M
Slightly volatile
Non Current Assets Total3.5 B3.3 B1.2 B
Slightly volatile
Cash And Short Term Investments84.3 M148.4 M174.1 M
Slightly volatile
Net Receivables185.2 M176.4 M94.2 M
Slightly volatile
Common Stock Shares Outstanding261.9 M249.4 M134.1 M
Slightly volatile
Liabilities And Stockholders Equity4.2 BB1.6 B
Slightly volatile
Non Current Liabilities Total1.4 B1.4 B398.1 M
Slightly volatile
Inventory230.5 M219.5 M103.5 M
Slightly volatile
Other Current Assets125.2 M119.2 M34 M
Slightly volatile
Other Stockholder Equity3.1 BB937.1 M
Slightly volatile
Total Liabilities1.7 B1.6 B474.3 M
Slightly volatile
Property Plant And Equipment Gross617.9 M588.5 M193.2 M
Slightly volatile
Total Current Assets696.7 M663.5 M410.1 M
Slightly volatile
Short Term Debt33 M31.5 M7.5 M
Slightly volatile
Intangible Assets1.7 B1.6 B501.7 M
Slightly volatile
Accounts Payable96.1 M91.5 M37.1 M
Slightly volatile
Common Stock Total Equity41.8 M39.8 M16.3 M
Slightly volatile
Common Stock23.4 M39.9 M36.3 M
Very volatile
Other Liabilities453.7 M432.1 M128.7 M
Slightly volatile
Good Will1.3 B1.2 B525.3 M
Slightly volatile
Property Plant Equipment240 M228.6 M104.2 M
Slightly volatile
Net Tangible Assets3.8 B3.6 B1.3 B
Slightly volatile
Retained Earnings Total Equity382.8 M649.8 M380.3 M
Slightly volatile
Long Term Debt Total1.8 M2.2 M2.3 M
Pretty Stable
Capital Surpluse3.1 BB935.4 M
Slightly volatile
Deferred Long Term Liabilities1.6 M1.7 M10.1 M
Slightly volatile
Non Current Liabilities Other51.7 M49.3 M15.4 M
Slightly volatile
Net Invested Capital1.7 B3.4 B1.3 B
Slightly volatile
Net Working Capital471.7 M463.4 M372.7 M
Slightly volatile
Capital Stock24.4 M39.9 M16.8 M
Slightly volatile
Short and Long Term Debt12 M22.2 M5.2 M
Slightly volatile

Neogen Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization151.7 M144.5 M46.5 M
Slightly volatile
Total Revenue1.1 BB505.3 M
Slightly volatile
Gross Profit508.8 M484.6 M241.8 M
Slightly volatile
Other Operating Expenses1.1 BB459.6 M
Slightly volatile
Cost Of Revenue571.5 M544.3 M263.5 M
Slightly volatile
Total Operating Expenses497.4 M473.7 M196.2 M
Slightly volatile
Selling General Administrative261 M248.5 M90.6 M
Slightly volatile
Research Development25.5 M24.3 M14.4 M
Slightly volatile
Selling And Marketing Expenses157.1 M165.4 M727.8 M
Slightly volatile
Interest IncomeM3.6 M2.2 M
Slightly volatile
Reconciled Depreciation151.7 M144.5 M49 M
Slightly volatile

Neogen Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow206 M196.2 M83.7 M
Slightly volatile
Depreciation151.7 M144.5 M46.6 M
Slightly volatile
Capital Expenditures126.3 M120.3 M41.8 M
Slightly volatile
End Period Cash Flow155.8 M148.4 M83.4 M
Slightly volatile
Stock Based Compensation14.8 M15.6 M7.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.211.285.3032
Slightly volatile
Days Sales Outstanding53.3456.3268.2013
Slightly volatile
Stock Based Compensation To Revenue0.01180.01740.0148
Very volatile
Capex To Depreciation1.350.961.0962
Pretty Stable
EV To Sales3.12.075.5112
Pretty Stable
Inventory Turnover1.72.232.4473
Very volatile
Days Of Inventory On Hand201169153
Very volatile
Payables Turnover10.266.848.9073
Slightly volatile
Sales General And Administrative To Revenue0.330.280.1757
Slightly volatile
Research And Ddevelopement To Revenue0.04920.02710.0361
Slightly volatile
Capex To Revenue0.110.11690.0642
Slightly volatile
Cash Per Share0.550.541.4626
Pretty Stable
Interest Coverage0.140.15663
Slightly volatile
Days Payables Outstanding46.6470.645.2995
Slightly volatile
Intangibles To Total Assets0.680.650.4014
Slightly volatile
Current Ratio5.42.987.2363
Slightly volatile
Receivables Turnover6.266.715.402
Slightly volatile
Capex Per Share0.460.430.2361
Slightly volatile
Revenue Per Share3.93.713.4087
Slightly volatile
Interest Debt Per Share4.294.081.3357
Slightly volatile
Debt To Assets0.320.30.116
Slightly volatile
Graham Number8.628.217.0806
Slightly volatile
Operating Cycle274241223
Very volatile
Days Of Payables Outstanding46.6470.645.2995
Slightly volatile
Quick Ratio3.892.05.565
Pretty Stable
Net Income Per E B T0.861.110.8181
Slightly volatile
Cash Ratio0.980.671.4866
Slightly volatile
Cash Conversion Cycle232171181
Slightly volatile
Days Of Inventory Outstanding200169153
Very volatile
Days Of Sales Outstanding53.3456.3268.2013
Slightly volatile
Fixed Asset Turnover2.742.894.7386
Slightly volatile
Debt Ratio0.320.30.116
Slightly volatile
Price Sales Ratio1.211.285.3032
Slightly volatile
Asset Turnover0.280.30.5431
Slightly volatile
Gross Profit Margin0.560.540.4879
Slightly volatile

Neogen Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap580 M1.1 B2.1 B
Pretty Stable
Enterprise Value1.9 B1.8 B2.5 B
Slightly volatile

Neogen Fundamental Market Drivers

Forward Price Earnings16
Cash And Short Term Investments129 M

Neogen Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
25th of July 2024
Next Financial Report
View
29th of February 2024
Next Fiscal Quarter End
View
25th of July 2024
Next Fiscal Year End
View
30th of November 2023
Last Quarter Report
View
31st of May 2023
Last Financial Announcement
View

About Neogen Financial Statements

Neogen stakeholders use historical fundamental indicators, such as Neogen's revenue or net income, to determine how well the company is positioned to perform in the future. Although Neogen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Neogen's assets and liabilities are reflected in the revenues and expenses on Neogen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Neogen. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue6.4 M3.6 M
Total RevenueB1.1 B
Cost Of Revenue544.3 M571.5 M
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.28  0.33 
Research And Ddevelopement To Revenue 0.03  0.05 
Capex To Revenue 0.12  0.11 
Revenue Per Share 3.71  3.90 
Ebit Per Revenue 0.01  0.01 

Currently Active Assets on Macroaxis

When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:
Check out the analysis of Neogen Correlation against competitors.
For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Neogen have expansion opportunities? Factors like these will boost the valuation of Neogen. Anticipated expansion of Neogen directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Neogen demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth
(0.86)
Earnings Share
(2.78)
Revenue Per Share
4.054
Quarterly Revenue Growth
(0.03)
Return On Assets
(0)
Investors evaluate Neogen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Neogen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Neogen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Neogen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Neogen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Neogen's market price signifies the transaction level at which participants voluntarily complete trades.